CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,000 | -93.9% | 44,924 | -89.5% | 0.00% | -100.0% |
| Q1 2022 | $866,000 | -12.3% | 428,506 | +17.6% | 0.00% | 0.0% |
| Q4 2021 | $987,000 | +1518.0% | 364,386 | +2548.9% | 0.00% | – |
| Q3 2021 | $61,000 | -52.7% | 13,756 | -38.2% | 0.00% | – |
| Q2 2021 | $129,000 | -67.4% | 22,243 | -60.6% | 0.00% | – |
| Q1 2021 | $396,000 | +360.5% | 56,400 | +284.3% | 0.00% | – |
| Q3 2020 | $86,000 | -63.1% | 14,677 | -59.9% | 0.00% | – |
| Q1 2020 | $233,000 | -96.4% | 36,567 | -94.2% | 0.00% | -100.0% |
| Q4 2019 | $6,533,000 | -14.0% | 626,531 | -67.6% | 0.01% | -22.2% |
| Q3 2019 | $7,595,000 | -50.5% | 1,932,514 | +87.3% | 0.01% | -52.6% |
| Q2 2019 | $15,346,000 | +15.1% | 1,032,012 | +92.1% | 0.02% | +11.8% |
| Q1 2019 | $13,335,000 | +184.1% | 537,279 | +105.6% | 0.02% | +142.9% |
| Q4 2018 | $4,693,000 | -66.7% | 261,310 | -45.5% | 0.01% | -58.8% |
| Q3 2018 | $14,093,000 | -19.8% | 479,850 | +24.2% | 0.02% | -26.1% |
| Q2 2018 | $17,572,000 | -38.6% | 386,458 | -28.6% | 0.02% | -41.0% |
| Q1 2018 | $28,598,000 | -8.3% | 541,630 | +18.1% | 0.04% | -11.4% |
| Q4 2017 | $31,191,000 | -2.9% | 458,684 | +17.6% | 0.04% | -12.0% |
| Q3 2017 | $32,136,000 | -71.4% | 390,012 | -67.5% | 0.05% | -73.0% |
| Q2 2017 | $112,331,000 | +1.7% | 1,199,731 | -30.8% | 0.18% | -4.6% |
| Q1 2017 | $110,434,000 | +222.2% | 1,734,472 | +124.8% | 0.19% | +228.8% |
| Q4 2016 | $34,276,000 | +130.8% | 771,637 | +87.3% | 0.06% | +118.5% |
| Q3 2016 | $14,850,000 | +82.4% | 411,949 | -30.6% | 0.03% | +80.0% |
| Q2 2016 | $8,143,000 | -60.7% | 593,481 | -45.0% | 0.02% | -59.5% |
| Q1 2016 | $20,716,000 | -37.9% | 1,078,921 | +13.3% | 0.04% | -24.5% |
| Q4 2015 | $33,338,000 | -3.7% | 952,519 | +153.0% | 0.05% | -3.9% |
| Q3 2015 | $34,624,000 | +105.7% | 376,504 | +96.5% | 0.05% | +104.0% |
| Q2 2015 | $16,835,000 | +22.7% | 191,568 | +3.6% | 0.02% | +19.0% |
| Q1 2015 | $13,722,000 | +44.9% | 184,858 | +9.3% | 0.02% | +75.0% |
| Q4 2014 | $9,472,000 | +1.1% | 169,149 | -18.1% | 0.01% | 0.0% |
| Q3 2014 | $9,366,000 | -37.0% | 206,468 | -42.5% | 0.01% | -40.0% |
| Q2 2014 | $14,866,000 | -58.7% | 358,989 | -30.9% | 0.02% | -60.8% |
| Q1 2014 | $35,978,000 | -0.7% | 519,385 | -13.6% | 0.05% | +4.1% |
| Q4 2013 | $36,247,000 | -11.0% | 601,413 | -10.3% | 0.05% | -24.6% |
| Q3 2013 | $40,741,000 | +50.9% | 670,305 | +66.2% | 0.06% | +27.5% |
| Q2 2013 | $27,006,000 | – | 403,201 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |